GenTek Announces Closure of its Newark, N.J. Sulfuric Acid Production Plant
03 Novembre 2006 - 9:50PM
Business Wire
GenTek Inc. (NASDAQ: GETI) today announced that it will be closing
its Newark, N.J. sulfuric acid production plant at the end of this
year. The production and shipment of other products, aluminum
sulfate and ferric sulfate, currently being sold from the Newark,
N.J. location will continue without any interruptions. GenTek�s
decision was driven by the fact that the Newark Sulfur operation,
already cash flow negative, was facing increasingly adverse market
conditions and required infrastructure investments, which would
have lead to material cash losses in this business. It is
anticipated that shipment of product will cease during December of
2006 and all closure activities are expected to be completed by the
end of April of 2007. The Company is currently negotiating with a
third party on the potential sale of the site. The restructuring
charges as a result of this closure include termination costs of
approximately $1 million and other closure costs totaling
approximately $1 million, substantially all of which are expected
to be paid in 2007. About GenTek Inc. GenTek provides specialty
inorganic chemical products and services for treating water and
wastewater, petroleum refining, and the manufacture of
personal-care products, valve-train systems and components for
automotive engines and wire harnesses for large home appliance and
automotive suppliers. GenTek operates over 60 manufacturing
facilities and technical centers and has more than 6,500 employees.
GenTek�s 2,000-plus customers include many of the world�s leading
manufacturers of cars and trucks, heavy equipment, appliances and
office equipment, in addition to global energy companies and makers
of personal-care products. Additional information about the Company
is available at www.gentek-global.com. Non-GAAP Financial Measures
This release contains non-GAAP financial measures within the
meaning of Regulation G promulgated by the Securities and Exchange
Commission. Included in this release is a reconciliation of the
differences between these non-GAAP financial measures and the most
directly comparable financial measures calculated in accordance
with GAAP. Forward-looking statements This press release includes
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Certain statements, other
than statements of historical facts, included herein may constitute
forward-looking statements. We have based these forward-looking
statements on our current expectations and projections about future
events. Although we believe that our assumptions made in connection
with the forward-looking statements are reasonable, there can be no
assurances that these assumptions and expectations will prove to
have been correct. Important factors that could cause actual
results to differ from these expectations include, among others,
our outstanding indebtedness and leverage; the impact of the
restrictions imposed by our indebtedness; our ability to fund and
execute our business plan; potential adverse developments with
respect to our liquidity or results of operations; the high degree
of competition in certain of our businesses, and the potential for
new competitors to enter into those businesses; continued or
increased price pressure in our markets; customers and suppliers
seeking contractual and credit terms less favorable to us; our
ability to maintain customers and suppliers that are important to
our operations; our ability to attract and retain new customers;
the impact of possible substantial future cash funding requirements
for our pension plans, including if investment returns on pension
assets are lower than assumed; the impact of any possible failure
to achieve targeted cost reductions; increases in the cost of raw
materials, including energy and other inputs used to make our
products; future modifications to existing laws and regulations
affecting the environment, health and safety; discovery of unknown
contingent liabilities, including environmental contamination at
our facilities; suppliers� delays or inability to deliver key raw
materials; breakdowns or closures of our or certain of our
customers� plants or facilities; inability to obtain sufficient
insurance coverage or the terms thereof; domestic and international
economic conditions, fluctuations in interest rates and in foreign
currency exchange rates; the cyclical nature of certain of our
businesses and markets; the potential that actual results may
differ from the estimates and assumptions used by management in the
preparation of the consolidated financial statements; future
technological advances which may affect our existing product lines;
the potential exercise of our Tranche B and Tranche C warrants and
other events could have a substantial dilutive effect on our common
stock; and other risks detailed from time to time in our SEC
reports. We undertake no obligation to publicly update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise. In light of these risks,
uncertainties and assumptions, the forward-looking events discussed
in this press release might not occur. GenTek Inc. (NASDAQ: GETI)
today announced that it will be closing its Newark, N.J. sulfuric
acid production plant at the end of this year. The production and
shipment of other products, aluminum sulfate and ferric sulfate,
currently being sold from the Newark, N.J. location will continue
without any interruptions. GenTek's decision was driven by the fact
that the Newark Sulfur operation, already cash flow negative, was
facing increasingly adverse market conditions and required
infrastructure investments, which would have lead to material cash
losses in this business. It is anticipated that shipment of product
will cease during December of 2006 and all closure activities are
expected to be completed by the end of April of 2007. The Company
is currently negotiating with a third party on the potential sale
of the site. The restructuring charges as a result of this closure
include termination costs of approximately $1 million and other
closure costs totaling approximately $1 million, substantially all
of which are expected to be paid in 2007. About GenTek Inc. GenTek
provides specialty inorganic chemical products and services for
treating water and wastewater, petroleum refining, and the
manufacture of personal-care products, valve-train systems and
components for automotive engines and wire harnesses for large home
appliance and automotive suppliers. GenTek operates over 60
manufacturing facilities and technical centers and has more than
6,500 employees. GenTek's 2,000-plus customers include many of the
world's leading manufacturers of cars and trucks, heavy equipment,
appliances and office equipment, in addition to global energy
companies and makers of personal-care products. Additional
information about the Company is available at
www.gentek-global.com. Non-GAAP Financial Measures This release
contains non-GAAP financial measures within the meaning of
Regulation G promulgated by the Securities and Exchange Commission.
Included in this release is a reconciliation of the differences
between these non-GAAP financial measures and the most directly
comparable financial measures calculated in accordance with GAAP.
Forward-looking statements This press release includes
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Certain statements, other
than statements of historical facts, included herein may constitute
forward-looking statements. We have based these forward-looking
statements on our current expectations and projections about future
events. Although we believe that our assumptions made in connection
with the forward-looking statements are reasonable, there can be no
assurances that these assumptions and expectations will prove to
have been correct. Important factors that could cause actual
results to differ from these expectations include, among others,
our outstanding indebtedness and leverage; the impact of the
restrictions imposed by our indebtedness; our ability to fund and
execute our business plan; potential adverse developments with
respect to our liquidity or results of operations; the high degree
of competition in certain of our businesses, and the potential for
new competitors to enter into those businesses; continued or
increased price pressure in our markets; customers and suppliers
seeking contractual and credit terms less favorable to us; our
ability to maintain customers and suppliers that are important to
our operations; our ability to attract and retain new customers;
the impact of possible substantial future cash funding requirements
for our pension plans, including if investment returns on pension
assets are lower than assumed; the impact of any possible failure
to achieve targeted cost reductions; increases in the cost of raw
materials, including energy and other inputs used to make our
products; future modifications to existing laws and regulations
affecting the environment, health and safety; discovery of unknown
contingent liabilities, including environmental contamination at
our facilities; suppliers' delays or inability to deliver key raw
materials; breakdowns or closures of our or certain of our
customers' plants or facilities; inability to obtain sufficient
insurance coverage or the terms thereof; domestic and international
economic conditions, fluctuations in interest rates and in foreign
currency exchange rates; the cyclical nature of certain of our
businesses and markets; the potential that actual results may
differ from the estimates and assumptions used by management in the
preparation of the consolidated financial statements; future
technological advances which may affect our existing product lines;
the potential exercise of our Tranche B and Tranche C warrants and
other events could have a substantial dilutive effect on our common
stock; and other risks detailed from time to time in our SEC
reports. We undertake no obligation to publicly update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise. In light of these risks,
uncertainties and assumptions, the forward-looking events discussed
in this press release might not occur.
Gentek (NASDAQ:GETI)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Gentek (NASDAQ:GETI)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025